A company dispute with Chinese shareholders can arise from various flashpoints, ranging from opaque decision-making to the improper allotment of shares designed to dilute minority interests.
With the full implementation of China's 2024 Company Law, the stakes for transparency have never been higher.
Foreign investors often find themselves at a disadvantage when local partners leverage "proper purpose" loopholes to shift corporate control.
Understanding the intersection of contract law, fiduciary duties, and recent judicial interpretations is essential for any stakeholder seeking to resolve disputes without sacrificing equity or operational influence in the Chinese market.
The Game-Changer: Personal Claims vs. Company Claims
For decades, the "rule in Foss v. Harbottle" made it nearly impossible for minority shareholders to sue.
It stated that if a company was wronged (e.g., directors sold shares at too low a price), only the company itself could sue.
Since the wrongdoers usually controlled the company, they obviously wouldn't sue themselves.
The New Reality:
Recent rulings have clarified that an improper share allotment affects your individual contract with the company.
When directors issue shares specifically to dilute your voting power (like pushing you below 25% so you can't block resolutions), they aren't just hurting the company's value—they are breaching your personal rights.
This grants you "standing" to sue directly to have those new shares cancelled.
👉 For deeper insights into your statutory protections, review our guide on Shareholders' Rights in China.
Improper Share Allotment: The "Poison Pill" Strategy
A common tactic in a company dispute with Chinese shareholders is for the majority to flood the market with new shares. This dilutes a minority rival's stake, rendering their vote meaningless.
The "Proper Purpose" Test:
Courts now apply a strict test: What was the primary motive for issuing these shares?
- Proper Purpose: Raising capital to build a factory or pay off debt.
- Improper Purpose: Issuing shares to a friendly party solely to outvote a rival or prevent a takeover.
If the court finds the primary motive was to manipulate control, the share issuance is voidable.
In the Tianrui case, the court found that issuing convertible bonds was a tactic to dilute a rival below 25%, preventing them from blocking special resolutions. This was ruled an "improper purpose".
👉 Read Related Article: Asset Freeze and Interim Measures
Ratification: The Majority Can't Just "Vote It Okay"
Usually, if directors make a mistake, shareholders can vote to "forgive" it (ratify). But what if the shareholders voting to forgive are the same ones benefiting from the scheme?
The Anti-Oppression Shield:
The new legal standard prevents majority shareholders from ratifying a breach of duty if doing so constitutes "oppression of the minority."
If the directors and the majority shareholders are working together (acting in concert) to dilute you, their vote to approve the share issuance is invalid.
The court will see through the charade and strike it down.
Common Triggers for Shareholder Disputes in China
Most disputes are not born overnight; they are the result of cumulative governance failures. In the Chinese context, these often center on:
- Improper Share Issuance: Using capital increases to "squeeze out" a minority partner.
- Profit Distribution Conflicts: Controlling shareholders refusing to issue dividends despite the company being revenue-positive.
- Governance Deadlocks: 50/50 joint ventures where neither party can pass a resolution, stalling operations.
- Breach of Fiduciary Duty: Directors or "Legal Representatives" acting in their own interest rather than the company's.
Options for Resolution in China
When facing a company dispute with China shareholders, litigation isn't your only path.
- Negotiation: The fastest and cheapest route. Use the threat of the new "personal claim" laws to force a settlement or a buyout of your shares.
- Administrative Complaint: You can report the improper issuance to the local Administration for Market Regulation (AMR), which can sometimes freeze corporate changes during an investigation.
- Litigation: Filing a civil lawsuit in People's Court to declare the board resolution invalid.
- Arbitration: If your Shareholders' Agreement has an arbitration clause (e.g., CIETAC), you must go there instead of the court. This is often faster and more neutral for foreign investors.
FAQs About Company Dispute with China Shareholders
Can I sue the company directly if my shares are diluted?
Yes, under the new legal precedents (like Tianrui), if the dilution was done for an "improper purpose" (like trying to destroy your voting power), you have a personal right to sue the company to have those shares cancelled. (Read More: Can You Sue a Chinese Company?)
What is the difference between a "derivative action" and a "personal claim"?
A derivative action is when you sue on behalf of the company for a loss the company suffered (e.g., directors stole money). A personal claim is when you sue for a loss you suffered personally (e.g., your voting rights were stripped away). Personal claims are generally faster and give you more control.
What counts as an "improper purpose" for issuing shares?
Issuing shares is improper if the primary goal is to manipulate control of the company, such as defeating a takeover bid or diluting a specific shareholder, rather than raising legitimate capital for business operations.
Can the majority shareholders just vote to approve the directors' bad actions?
Not always. If the ratification (approval) itself is an act of "minority oppression"—meaning the majority is using their votes to hurt you—the court can declare that vote invalid.
Is arbitration better than court for shareholder disputes in China?
It depends. Arbitration (like CIETAC) is confidential, final (no appeals), and generally more neutral for foreigners. However, courts have more power to order immediate interim measures (like freezing assets). Check your Shareholders' Agreement to see which one you are required to use.
Conclusion
A company dispute with China shareholders is a high-stakes chess match where the rules have recently been rewritten. Success depends on moving beyond emotional conflict and focusing on the rigid procedural requirements of the 2024 Company Law. By asserting your information rights early and being prepared to challenge improper board actions, you can protect the value of your investment from predatory tactics.
Subscribe to receive updates
Subscribe to receive the latest blog posts to your inbox every week.
